Skip to content

Effectiveness of Sodium Restriction in Japanese patients with Chronic Heart Failure

Effectiveness of Sodium Restriction in Japanese patients with Chronic Heart Failure - Effectiveness of Sodium Restriction in Japanese patients with Chronic Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026665
Enrollment
200
Registered
2017-03-23
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

The control group followed a diet with normal sodium restriction(maximum dietary intake, 6g/d), carried out until day8. The study intervention consisted of strict sodium restriction(maximum dietary in

Sponsors

Tokyo Women's Medical University, Department of Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria are included in this study. 1.Patients who are admitted to Tokyo women's medical university cardiology department. 2.Patients who are at age of 20 at the time of consenting. 3.The heart failure is diagnosed according to Framingham criteria. 4.Patients with heart failure classified as AHA stage C to D. 5.Patients who are capable of giving their consent in a written form.

Exclusion criteria

Exclusion criteria: 1.Patients are admitted as Acute heart failure, Acute on chronic heart failure,and who need using mechanical support or infusion of a diuretic. 2.Acute coronary syndrome require emergent revascularization. 3.Patients who are pathologically difficult to ingest. 4.Patients with dialysis therapy. 5.Patients with Na levels =< 130 mEq/L 6.Patients with Hb levels =< 10.0mg/dl 7.Patients with malignancy(except those who are completely cured) 8.Patients with infection treatment. 9.Patients with other conditions that the attending physician think inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
clinical stability(clinical congestion score: CCS) at 7-day assessment is the primary end point.

Secondary

MeasureTime frame
BNP, NT-proBNP, ANP, body weight, use of diuretics, sodium, Inbody, CTR, QOL

Countries

Japan

Contacts

Public ContactKimura Makiko

Tokyo Womens Medical University Cardiology

makiko01035@hotmail.co.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026